Dalal Alqahtani

Saudi Food and Drug Authority, Saudi Arabia

Poster(s):

• (B-290) The Effectiveness of the Safety Communication for Concurrent Benzodiazepine-Opioid Therapy: A Retrospective Real-World Analysis
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET